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Summary
A straightforward approach for the synthesis of several new, aryl-substituted derivatives of the conformationally
constrained phenylalanine analogue 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (Tic) is described. Tic, nitro-
substituted at the 6 or 7 position, was prepared by base-catalyzed cyclization of diethyl acetamidomalonate with
α,α-dibromo-4-nitro-o-xylene followed by decarboxylation and deacylation under refluxing conditions in aqueous
HCl. Catalytic hydrogenation of nitro-Tic in the presence of 10% Pd/C afforded amino-Tic, which was then
converted to iodo-Tic by a modified Sandmeyer reaction. Both amino-Tic and iodo-Tic can easily be transformed
to other substituents.
Introduction
The use of conformational restrictions for the devel-
opment of topographically well-defined peptide ana-
logues with improved potency and/or selectivity is
an established approach in peptide-based drug de-
sign. Toward this end, 1,2,3,4-tetrahydroisoquinoline-
3-carboxylic acid (Tic) has seen increased use as a
conformationally constrained phenylalanine analogue
in the synthesis of peptide analogues [1–5] with well-
defined side-chain orientations. Although the tetrahy-
droisoquinoline ring system structurally provides sev-
eral positions for further modification of Tic in order
to probe features of the ligand binding site, relatively
few Tic derivatives have been reported, largely due to
limitations in the standard approach for the synthesis
of Tic. We describe here an alternate approach more
suitable for the synthesis of a wide variety of modified
Tic analogues.
Tic is generally synthesized by a Pictet-Spengler
reaction [6] using phenylalanine with formaldehyde
in the presence of concentrated hydrochloric acid un-
der refluxing conditions. However, this method is not
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widely suitable for ring-substituted phenylalanine ana-
logues since the Pictet-Spengler reaction is usually
limited to analogues in which the ring-substituents in-
crease electron density at the point of ring closure
to facilitate cyclization [7]. For example, 3-hydroxy-
phenylalanine [8], 3-methoxy-phenylalanine [9],
3,4-dihydroxy-phenylalanine [10,11], 3,4-dimethoxy-
phenylalanine [11,12], and 3,4-methanediyldioxy-
phenylalanine [13] have been cyclized successfully
to their corresponding Tic analogues directly through
this reaction or via a modification to this process.
However, tyrosine failed to yield 7-hydroxy-Tic due
to a polymerization reaction to a phenol-formaldehyde
polymer. Conversely, 3′,5′-diiodo-L-tyrosine or 3′,5′-
dibromo-L-tyrosine, in which the positionsortho to
the phenolic OH are blocked by halogen atoms, were
successfully cyclized by a modified procedure [14].
Phenylalanine derivatives lacking activating groups
such as alkoxy or hydroxy functions have rarely been
cyclized. One exception is 4-fluoro-phenylalanine,
from which 7-fluoro-Tic was prepared [15]. However,
the use of similar conditions for the attempted synthe-
sis of 7-chloro-Tic was unsuccessful in our hands. Tic
analogues with even more electron-withdrawing sub-
stituents, such as a nitro group, which could readily
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be converted to other moieties, are inaccessible via the
Pictet-Spengler reaction. Consequently, we undertook
the alternative pathway [16,17] depicted in Schemes
1 and 2 for the synthesis of Tic derivatives with several
different possible substituents, each derived from a ni-
tro group introduced at the initial stage of the reaction
route, at the 6 or 7 positions.
Materials and Methods
Chemicals were purchased from Aldrich Chemical
Company, Inc. Thin-layer chromatography (TLC)
was performed on glass plates precoated with sil-
ica gel (Analtech). Products were visualized by UV
(254 nm), and purified by flash chromatography (sil-
ica gel, 70–230 mesh, 60 Å, Aldrich). Melting points
were determined on a Haake Buchler Melting Point
Apparatus and were not corrected.1H NMR spec-
tra were recorded on Bruker DPX300 and DRX500
spectrometers. Elemental analysis was carried out at
the University of Michigan, Department of Chemistry.
Analytical RP-HPLC was performed on a C18 Vydac
column (0.46× 25 cm) using the solvent system: 0.1%
TFA (w/v) in water (solvent A)/0.1% TFA (w/v) in
acetonitrile (solvent B), at a flow rate of 1 ml/min.
The HPLC column eluates were monitored by their
UV absorbance at 230 nm.
Syntheses
Diethyl 2-acetyl-6-nitro-1,2,3,4-tetrahydroisoquino-
line-3,3-dicarboxylate (3a) and diethyl
2-acetyl-7-nitro-1,2,3,4-tetrahydroisoquinoline-3,3-
dicarboxylate (3b)
To a solution of diethyl acetamidomalonate (1.44 g,
6.50 mmol) in dry acetone was added sodium hydride
(60% dispersion in mineral oil, 0.51 g, 13 mmol),
followed by α,α-dibromo-4-nitro-o-xylene (2.01 g,
6.50 mmol), which had been prepared from 4-nitro-o-
xylene as described by Kleinschmidt and Braeuniger
[18] (see Scheme 1). The flask was placed in a pre-
heated oil bath and gently refluxed for 30 min (until
the starting material,α,α-dibromo-4-nitro-o-xylene,
was no longer visible by TLC). The reaction mix-
ture was then cooled to room temperature, evaporated,
and partitioned between H2O and EtOAc. The organic
layer was washed with brine, dried (MgSO4), and
concentrated. Analysis by TLC (hexane:EtOAc/1:1)
showed two major components with Rf values of 0.11
and 0.24. These compounds were separated by flash
column chromatography (silica gel). The more po-
lar component of the flash chromatography separation
was determined to be the 6-nitro product,3a (0.69 g,
29% yield).1H NMR (CDCl3): δ (ppm) 1.19 (m, 6H,
CH2CH3), 2.31 (s, 3H, COCH3), 3.54 (s, 2H, CH2C),
4.18 (m, 4H, CH2CH3), 4.79 (s, 2H, CH2N), 7.36 (d,
J = 8.3 Hz, 1H, aromatic), 8.08 (s, 1H, aromatic), 8.13
(d, J = 8.3 Hz, 1H, aromatic); mp 126–127◦C (re-
crystallized from EtOAc/hexane). Analysis by HPLC
(0–60% B/60 min) indicated a purity in excess of 95%,
with rt = 43.0 min. Elemental analysis: calculated for
C17H20N2O7: C, 56.04; H, 5.53; N, 7.69; found: C,
56.11; H, 5.53; N, 7.69.
The less polar component proved to be the 7-nitro
product,3b (0.95 g, 40% yield).1H NMR (CDCl3): δ
(ppm) 1.19 (m, 6H, CH2CH3), 2.31 (s, 3H, COCH3),
3.54 (s, 2H, CH2C), 4.17 (m, 4H, CH2CH3), 4.79 (s,
2H, CH2N), 7.38 (d, J = 8.2 Hz, 1H, aromatic), 8.10
(s, 1H, aromatic), 8.12 (d, J = 8.2 Hz, 1H, aromatic);
mp 102–103◦C (recrystallized from EtOAc/hexane).
Analysis by HPLC (0–60% B/60 min) indicated a pu-
rity in excess of 90% with rt = 43.2 min. Elemental
analysis: calculated for C17H20N2O7: C, 56.04; H,
5.53; N, 7.69; found: C, 56.13; H, 5.65; N, 7.80.
6-Nitro-1,2,3,4-tetrahydroisoquinoline-3-carboxylic
acid hydrochloride (4a)
Compound3a (0.64 g, 1.74 mmol) was suspended
in 10 ml 6 N HCl and held at reflux for 3–4 h. The
resulting cloudy solution was cooled to room temper-
ature, filtered, and dried to give4a as an off-white
solid (0.33 g, 73%). Since1H NMR showed no other
side products present,4a was used (see below) with-
out further purification.1H NMR (D2O): δ (ppm) 2.86
(dd, J = 10.4 Hz, J = 16.9 Hz, 1H, CH2CH), 3.10 (dd,
J = 4.7 Hz, J = 16.9 Hz, 1H, CH2CH), 3.45 (dd, J =
4.7 Hz, J = 10.4 Hz, 1H, CH2CH), 4.02 (d, J = 17.1 Hz,
1H, CH2N), 4.11 (d, J = 17.1 Hz, 1H, CH2N), 7.24
(d, J = 8.5 Hz, 1H, aromatic), 7.94 (d, J = 8.5 Hz,
1H, aromatic), 8.01 (s, 1H, aromatic); mp >220◦C
(decomp.); HPLC rt = 16.2 min (0–60% B/60 min);
ES-MS (M+H+): 223.1. Elemental analysis: calcu-
lated for C10H11N2O4Cl: C, 46.44; H, 4.28; N, 10.83;
found: C, 46.62; H, 4.42; N, 10.64.
7-Nitro-1,2,3,4-tetrahydroisoquinoline-3-carboxylic
acid hydrochloride (4b)
7-Nitro-1,2, 3, 4- tetrahydroisoquinoline-3-carboxylic
acid hydrochloride (4b) was synthesized in 90% yield
in a similar manner as described above for4a. 1H






















Scheme 1.Synthesis of 6-nitro or 7-nitro-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride.
17.4 Hz, 1H, CH2CH), 3.08 (dd, J = 4.6 Hz, J =
17.4 Hz, 1H, CH2CH), 3.43 (dd, J = 4.6 Hz, J =
10.4 Hz, 1H, CH2CH), 3.88 (d, J = 16.2 Hz, 1H,
CH2N), 4.07 (d, J = 16.2 Hz, 1H, CH2N), 7.29 (d,
J = 8.4 Hz, 1H, aromatic), 7.92 (m, 2H, aromatic);
mp >220◦C (decomp.); HPLC rt = 16.5 min (0–60%
B/60 min); ES-MS (M+H+): 223.0. Elemental analy-
sis: calculated for C10H11N2O4Cl: C, 46.44; H, 4.28;
N, 10.83; found: C, 46.74; H, 4.47; N, 10.44.
6-Amino-1,2,3,4-tetrahydroisoquinoline-3-carboxylic
acid hydrochloride (5a)
A hydrogenation bottle was charged with compound
4a (0.26 g, 1.01 mmol) in 20 ml MeOH and to it
was added 10% Pd/C (0.03 g). The suspension was
hydrogenated at 30 psi for 1 h (until no further uptake
of hydrogen was observed). The suspension was fil-
trated through Celiter and evaporated to give5a as
a light yellow solid (0.22 g, 96%). This product was
sufficiently pure, as indicated by1H NMR, to be used
directly in the next step.1H NMR (D2O): δ (ppm) 3.20
(dd, J = 10.9 Hz, J = 17.4 Hz, 1H, CH2CH), 3.43 (dd,
J = 5.1 Hz, J = 17.4 Hz, 1H, CH2CH), 4.05 (dd, J =
5.1 Hz, J = 10.9 Hz, 1H, CH2CH), 4.36 (d, J = 15.9 Hz,
1H, CH2N), 4.53 (d, J = 15.9 Hz, 1H, CH2N), 7.27
(m, 2H, aromatic), 7.40 (d, J = 8.0 Hz, 1H, aromatic);
mp >230◦ C (decomp.); HPLC rt = 3.0 min (0–20%




acid hydrochloride (5b) was synthesized in 98% yield
using the procedure described above for5a. 1H NMR
(D2O): δ (ppm) 3.16 (dd, J = 10.8 Hz, J = 17.4 Hz,
1H, CH2CH), 3.42 (dd, J = 5.3 Hz, J = 17.4 Hz, 1H,
CH2CH), 4.09 (dd, J = 5.3 Hz, J = 10.8 Hz, 1H,
CH2CH), 4.39 (d, J = 16.0 Hz, 1H, CH2N), 4.51 (d,
J = 16.0 Hz, 1H, CH2N), 7.26 (s, 1H, aromatic), 7.31
(d, J = 8.2 Hz, 1H, aromatic), 7.42 (d, J = 8.24 Hz, 1H,
aromatic); mp >210◦C (decomp.); HPLC rt = 3.0 min
(0–20% B/20 min); ES-MS (M+H+): 193.1.
6-Iodo-1,2,3,4-tetrahydroisoquinoline-3-carboxylic
acid (6a)
To a solution of5a (0.22 g, 0.96 mmol) in 3 ml 10%
H2SO4 at 0 ◦C was added, dropwise, a precooled
aqueous solution of NaNO2 (0.07 g, 1.01 mmol,
0.5 ml H2O). The resulting diazonium salt solution
was stirred at 0◦C for 30 min to 1 h, followed by the
addition of a few crystals of urea, to decompose any
extra nitrous acid, and KI (1.60 g, 9.64 mmol). The
dark mixture was stirred at room temperature for an-
other 2 h and extracted with EtOAc. The organic layer
was then washed with an aqueous solution of Na2SO3
resulting in the precipitation of an off-white solid,
which was filtered and dried to give the title product
(0.22 g, 75% yield).1H NMR (D2O/NaOD):δ (ppm)
2.67 (dd, J = 10.9 Hz, J = 16.5 Hz, 1H, CH2CH), 2.88
(dd, J = 4.7 Hz, J = 16.5 Hz, 1H, CH2CH), 3.31 (dd,
J = 4.7 Hz, J = 10.9 Hz, 1H, CH2CH), 3.73 (d, J =
16.1 Hz, 1H, CH2N), 3.87 (d, J = 16.1 Hz, 1H, CH2N),
6.79 (d, J = 8.0 Hz, 1H, aromatic), 7.42 (d, J = 8.0 Hz,
1H, aromatic), 7.48 (s, 1H, aromatic); mp >200◦C






















Scheme 2.Synthesis of compounds7a and7b.
7-Iodo-1,2,3,4-tetrahydroisoquinoline-3-carboxylic
acid (6b)
7-Iodo-1,2, 3, 4-tetrahydroisoquinoline- 3 -carboxylic
acid (6b) was synthesized in 75% yield using
the procedure described above for6a. 1H NMR
(D2O/NaOD): δ (ppm) 2.71 (dd, J = 10.6 Hz, J =
16.7 Hz, 1H, CH2CH), 2.94 (dd, J = 4.4 Hz, J =
16.7 Hz, 1H, CH2CH), 3.37 (dd, J = 4.5 Hz, J =
10.6 Hz, 1H, CH2CH), 3.81 (d, J = 16.2 Hz, 1H,
CH2N), 3.93 (d, J = 16.2 Hz, 1H, CH2N), 6.92 (d,
J = 8.2 Hz, 1H, aromatic), 7.47 (s, 1H, aromatic)
7.48 (d, J = 8.2 Hz, 1H, aromatic); mp >230◦C




A solution of6a (0.19 g, 0.63 mmol) in a mixture of
THF (10 ml), water (10 ml), Et3N (0.13 g, 1.23 mmol)
and di-tert-butyldicarbonate (0.16 g, 0.75 mmol) was
stirred at 25◦C overnight. The solution was concen-
trated to about half the original volume, cooled in an
ice bath, covered with a layer of EtOAc, and acidified
to pH 2–3 with 5% aqueous citric acid. The aqueous
layer was extracted with EtOAc and the combined or-
ganic phase was dried (MgSO4) and evaporated. The
resulting residue was purified by flash column chro-
matography (silica gel, EtOAc:acetic acid/200:0.4) to
give 0.2 g of7a (79%). 1H NMR (CDCl3): δ (ppm)
1.44 and 1.53 (cisandtransconformers) (s, 9H, Boc),
3.1 (m, 2H, CH2CH), 4.4–4.7 (m, 2H, CH2N), 4.81
and 5.12 (m, 1H, CH2CHN), 6.88 (d, J = 7.8 Hz, 1H,
aromatic), 7.54 (m, 2H, aromatic). ES-MS (M+H+):
403.5. HPLC rt = 50.5 min (0–60% B/60 min).
2-Tert-Butoxycarbonyl-1,2,3,4-tetrahydro-7-iodo-
isoquinoline-3-carboxylic acid (7b)
2 -tert-Butoxycarbonyl-1,2, 3, 4-tetrahydro-7-iodoiso-
quinoline-3-carboxylic acid (7b) was synthesized in
86% yield using the procedure described above for
7a. 1H NMR (CDCl3): δ (ppm) 1.44 and 1.53 (cis
and trans conformers) (s, 9H, Boc), 3.1 (m, 2H,
CH2CH), 4.66 (m, 2H, CH2N), 4.80 and 5.13 (m, 1H,
CH2CHN), 6.92 (d, J = 7.8 Hz, 1H, aromatic), 7.51
(m, 2H, aromatic). ES-MS (M+H+): 403.5. HPLC rt
= 51.0 min (0–60% B/60 min).
Results and Discussion
Schemes 1 and 2 represent a convenient route for the
synthesis of aryl-substituted analogues of Tic in rea-
sonable yields. In Scheme 1, K2CO3 or Cs2CO3 can
also be used as the base to promote the condensa-
tion of α,α-dibromo-4-nitro-o-xylene (2) with diethyl
acetamidomalonate, but require longer reaction times
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and give rise to side products, as indicated by smears
on the TLC plates. Acetone was found to be superior
to other polar solvents such as THF, MeOH, or DMF
for this step, resulting in decreased reaction times and
improved purity. The two nitro regioisomers,3a and
3b, were assigned based on a one-dimensional dif-
ference nuclear Overhauser experiment, wherein the
irradiation of H-1 (δ = 4.79 ppm) in3a led to in-
creased intensity of a doublet (H-8,δ = 7.36 ppm) in
the aromatic proton region, while irradiation of H-1 (δ
= 4.79 ppm) in3b led to increased intensity of a singlet
(H-8, δ = 8.10 ppm).
The amino-Tic compounds5a and5b might have
minor contamination as suggested by the presence of
a light yellow color; however, these proved to be
difficult to purify by either crystallization or chro-
matography and were therefore carried on to the next
step in Scheme 2. The iodo-Tic derivatives,6aand6b,
which are only slightly soluble in water and other com-
mon organic solvents, were purified by first converting
to their corresponding Boc-derivatives7aand7busing
standard conditions, then purified by flash chromatog-
raphy (silica gel, AcOEt:AcOH/150:1) in 39 and 42%
yield, respectively.
Conclusions
Tic analogues substituted at the 6 or 7 position with
nitro, amino, or iodo groups have been synthesized
in reasonable yields in three to five steps. The ready
conversion of amino-Tic to iodo-Tic without the need
of protecting groups as well as the ease of isolating
iodo-Tic are advantages of this synthetic route. Further
conversions of the functionally versatile amino-Tic or
iodo-Tic to other Tic analogues are in progress and the
extension of this pathway to functionalize Tic at the 5
or 8 position is also planned.
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